School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
J Food Drug Anal. 2022 Mar 15;30(1):88-103. doi: 10.38212/2224-6614.3391.
A three-step stacking capillary electrophoresis (CE) composed of field-amplified sample injection, sweeping, and analyte focusing by micellar collapse (FASI-sweeping-AFMC) was developed to determine dabigatran (D) and its major active metabolite, dabigatran acyl-beta-d-glucuronide (DAG), in human plasma. After optimization and validation, this novel approach was further applied to monitor 5 real samples, and the 25.2-186.8 ng mL D could be observed among those. Based on these results, the novel CE stacking strategy was successfully applied for the analysis of D and DAG in human plasma and could be served as a tool for clinical assays.
建立了一种三步堆积毛细管电泳(CE)方法,包括场放大样品进样、扫集和胶束塌陷的分析物聚焦(FASI-扫集-AFMC),用于测定人血浆中的达比加群(D)及其主要活性代谢物达比加群酰基-β-D-葡萄糖醛酸(DAG)。经过优化和验证后,该新方法进一步应用于监测 5 个真实样本,其中可观察到 25.2-186.8ngmL 的 D。基于这些结果,该新的 CE 堆积策略成功地应用于人血浆中 D 和 DAG 的分析,可以作为临床检测的工具。